Gilead Sciences Inc (NASDAQ:GILD) on 07/25/2018 declared a dividend of $ 0.5700 per share payable on September 27, 2018 to shareholders of record as of September 14, 2018.

Gilead Sciences Inc (NASDAQ:GILD) has paid dividends since 2015, has a current dividend yield of 2.94% and has increased its dividends for 2 successive years.

Gilead Sciences Inc's market cap is $ 100,965,266,650 and has a PE ratio of 29.52. The stock price closed yesterday at $ 77.65 and has a 52 week low/high of $ 64.27 and $ 89.54.

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co. focuses on human immunodeficiency virus, liver diseases such as chronic hepatitis C virus infection and chronic hepatitis B virus infection, cardiovascular, hematology/oncology and inflammation/respiratory. Co. owns or has rights to various trademarks, copyrights and trade names used in its business, including: GILEAD®, GILEAD SCIENCES®, AMBISOME®, CAYSTON®, COMPLERA®, DESCOVY®, EMTRIVA®, EPCLUSA®, EVIPLERA®, GENVOYA®, HARVONI®, HEPSERA®, LETAIRIS®, ODEFSEY®, RANEXA®, SOVALDI®, STRIBILD®, TRUVADA®, TYBOST®, VEMLIDY®, VIREAD®, VITEKTA®, VOLIBRIS® and ZYDELIG®.

For more information on Gilead Sciences Inc click here.